Navigation Links
Human Cells Used to Make Replacement Anal Sphincters in Mice
Date:8/10/2011

WEDNESDAY, Aug. 10 (HealthDay News) -- The first working, replacement anal sphincters have been built in a laboratory and tested on mice.

Now scientists hope the research will benefit humans with fecal and urinary incontinence, because current methods used to repair internal anal sphincters, such as skeletal muscle grafts, silicone injections or mechanical implants, have had only limited success.

"In essence, we have built a replacement sphincter that we hope can one day benefit human patients. This is the first bioengineered sphincter made with both muscle and nerve cells, making it 'pre-wired' for placement in the body," senior author Khalil N. Bitar, a professor of regenerative medicine at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine, said in a Wake Forest news release.

Scientists were able to make the bioengineered anal sphincters in about six weeks using human muscle and nerve cells. They found the sphincters were able to generate blood supply and work properly in mice.

The investigators hope their research will lead to a more effective treatment for humans because there is a high rate of weakened internal anal sphincters in older adults. Women who had episiotomies during childbirth can also be affected by this condition.

"Many individuals find themselves withdrawing from their social lives and attempting to hide the problem from their families, friends, and even their doctors," said Bitar. "Many people suffer without help."

Repeated laboratory tests of the engineered sphincters showed they functioned normally, relaxing and contracting, in the mice. The sphincters were also re-tested after a period of 25 days and compared to the mice's original sphincters. The researchers found the man-made sphincters continued to work like natural ones.

The mice chosen for the experiment had suppressed immune systems to reduce the risk of rejection of the new sphincters, the study authors pointed out. Ultimately, the scientists said they hope to use the muscle and nerve cells of individual human patients to build personalized pre-wired sphincters, eliminating the risk of rejection.

"The engineered sphincters were physiologically similar to native tissue," said Bitar. "This takes us one step closer to realizing the goal of using a patient's own cells to engineer a replacement sphincter in the lab."

The authors concluded that their research could lead to the development of treatments for other conditions. "While we have numerous challenges to meet, we have crossed a major hurdle," noted Bitar. "This proof of concept research suggests that this strategy may be useful for treating a variety of neuromuscular conditions of the intestine. In addition, it could potentially be applied to other diseases of sphincter muscles, including urinary incontinence."

The study was published in a recent issue of the journal Gastroenterology.

More information

The U.S. National Library of Medicine has more on fecal incontinence.

-- Mary Elizabeth Dallas

SOURCE: Wake Forest Baptist Medical Center, news release, Aug. 9, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Education -- a key determinant of population growth and human well-being
2. Human Brains Wired to Empathize, Study Finds
3. Dolphins Superior Ability to Heal May Help Humans
4. Ancient Footprints Reveal Earliest Signs of Human-Like Gait
5. INFORMS: CARE positions disaster relief with promising discipline of humanitarian logistics
6. INFORMS journal announces special issue on using logistics, analytics in humanitarian relief
7. Dolphins remarkable recovery from injury offers important insights for human healing
8. Genetic map of African-Americans to aid study of diseases, human evolution
9. BIDMC to co-lead NIH consortium for AIDS vaccine research in nonhuman primates
10. IBD, LCPD health research in Westie dogs may hold answers to similar human diseases
11. Human Stem Cells Used to Fix Damaged Mouse Heart
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Human Cells Used to Make Replacement Anal Sphincters in Mice 
(Date:2/12/2016)... Washington, DC (PRWEB) , ... ... ... the Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to ... settings. The partnership will recruit top students from U.S. universities who will ...
(Date:2/12/2016)... Boca Raton, FL (PRWEB) , ... February 12, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – hosted over 250 members of South Florida’s philanthropic community at ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose Combination ... 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose combination ... garnering increased attention from all stakeholders in the development of new chemical entities. ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Each year, ... will be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical ... see new therapy products in action, learn more about their chosen field and network ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Va. , Feb. 12, 2016   National ... Hoey , RPh, MBA issued the following statement today ... released by the Centers for Medicare & ... raised by NCPA, beneficiary advocates and others: ... raised. We are still reviewing the full CMS analysis. ...
(Date:2/12/2016)...  This month,s issue of the Journal of ... in-depth look at various causes and consequences associated with rising health ... which has generated significant public outrage and calls for ... E. Happe , PharmD, MPH. --> JMCP ... --> In 2014 prescription drug spending in ...
(Date:2/12/2016)... PAULO , Feb. 12, 2016 ... commenced a cash tender offer (the "Tender Offer") ... million outstanding aggregate principal amount of its 6.500% ... and ISIN Nos. US44915JAA88/ USP5246AAF05) (the "Notes"). In ... soliciting (the "Consent Solicitation") consents (the "Consents") of ...
Breaking Medicine Technology: